QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel Cleared by FDA for Clinical Use

QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth ...

November 04, 2024 | Monday | News
Ate Therapeutics Grants 16,400 Restricted Stock Units to New Employees

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripot...

November 04, 2024 | Monday | News
American Lung Association Launches Free Lung Cancer Screenings for Illinois Residents in Honor of Lung Cancer Awareness Month

November is Lung Cancer Awareness Month, and the American Lung Association (Lung Association) is kicking it off by offering free lung cancer screenings to&...

November 01, 2024 | Friday | News
Yvonne Greenstreet of Alnylam Pharmaceuticals Reports 34% Revenue Growth in Q3, Driven by TTR Success and Strong Pipeline Progress

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, reported its consolidated financial results for the third quarter...

November 01, 2024 | Friday | News
Genentech Publishes Positive Phase III Results for Itovebi in Advanced Breast Cancer in NEJM

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that a detailed analysis of the positive Phase III INAVO120 results, evaluat...

November 01, 2024 | Friday | News
Eisai and Biogen Showcase Promising Long-Term Data for Lecanemab in Early Alzheimer’s Disease at CTAD 2023

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 01, 2024 | Friday | News
Roche Unveils Promising Data for Elecsys Amyloid Plasma Panel in Alzheimer’s Diagnosis at CTAD 2024

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced new late-breaking data on its Elecsys Amyloid Plasma Panel (combination of pTau181 and ApoE4), for Alzhei...

November 01, 2024 | Friday | News
Abzena Expands Quality Control Testing Capabilities at San Diego Facility, Elevating Biologics Manufacturing and Microbiology Standards

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) test...

October 31, 2024 | Thursday | News
Biogen and Neomorph Forge Collaboration to Develop Molecular Glue Degraders for Neurological and Immunological Diseases

 Biogen Inc. (Nasdaq: BIIB) and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority ta...

October 30, 2024 | Wednesday | News
Eli Lilly Reports Positive Phase 3b Results for Donanemab, Reducing Amyloid-Related Edema in Alzheimer's Patients

Eli Lilly and Company (NYSE: LLY) announced positive results from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related imaging...

October 30, 2024 | Wednesday | News
GSK Acquires CMG1A46 from Chimagen for $300 Million to Target B Cell-Driven Autoimmune Diseases

GSK plc (LSE/NYSE: GSK) and Chimagen Biosciences (Chimagen), a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a c...

October 30, 2024 | Wednesday | News
Novartis Secures FDA Accelerated Approval for Scemblix® in Newly Diagnosed CML Patients

Novartis announced that Scemblix® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients wit...

October 30, 2024 | Wednesday | News
MilliporeSigma Rolls Out €70 Million Expansion to Transform St. Louis into a Hub for Advanced ADC Manufacturing and Biopharma Innovation

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | Wednesday | News
PL Developments Secures FDA Approval for Omeprazole OTC and Successfully Refinances Corporate Debt

PL Developments (PLD), a leader in the development, manufacturing, packaging, and distribution of consumer healthcare products, announced two significant m...

October 29, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close